sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 101-125 out of 1416.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>

Public Release: 28-Sep-2017
Indonesian prisoners with HIV getting aid from UIC researchers
The University of Illinois at Chicago College of Nursing has received a four-year federal grant to assist HIV-positive prisoners in Indonesia -- a southeast Asian country where the number of new infections is increasing rapidly.
NIH/National Institute on Drug Abuse

Contact: Sam Hostettler
University of Illinois at Chicago

Public Release: 28-Sep-2017
Partners receive $4.25 million to develop universal surveillance platform for disease outbreaks
During this multi-year program, Ceres Nanosciences and Tasso, Inc. will partner on a device for simple, painless collection of large-volume capillary blood samples in remote environments, working with infectious disease experts and advanced biodefense laboratories at George Mason University and United States Army Medical Research Institute of Infectious Diseases. Their goal is to develop an effective disease surveillance platform that can be rapidly deployed in the field, operated by untrained users, and improve early response.
Defense Threat Reduction Agency

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 28-Sep-2017
BMJ Global Health
New triage tool helps doctors save lives when resources are most limited
An international team of researchers has developed a simple way for healthcare providers to quickly identify and prioritize patients at the greatest risk of death.
University of Virginia Center for Global Health, National Institutes of Health, UVA Pfizer Initiative in International Health, UVA undergraduate Harrison Research Award to Riley Hazard under the supervision of Moore and Barnes

Contact: Josh Barney
University of Virginia Health System

Public Release: 28-Sep-2017
A single mutation in Zika virus results in microcephaly
One single genetic change, likely acquired in 2013, gave the Zika virus the ability to cause severe fetal microcephaly, researchers report.

Contact: Science Press Package
American Association for the Advancement of Science

Public Release: 27-Sep-2017
University of Hawaii awarded nearly $6.3 million to develop trivalent Ebola vaccine
University of Hawaii vaccine researcher Axel Lehrer, Ph.D., has received a $6.35 million grant to test whether the Ebola vaccine formula he has developed will protect against two additional viruses in the same family.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Tina Shelton
University of Hawaii Cancer Center

Public Release: 27-Sep-2017
Science Translational Medicine
New test rapidly diagnoses Zika
MIT researchers have developed a paper-based test that can diagnose Zika infection within 20 minutes. Unlike existing tests, the new diagnostic does not cross-react with Dengue virus, a close relative of the Zika virus that can produce false positives on many Zika tests.
US Public Health Service and the Science, Technology and Innovation Fund of Colombia

Contact: Sarah McDonnell
Massachusetts Institute of Technology

Public Release: 26-Sep-2017
Research!America to honor Chair Emeritus The Honorable John Edward Porter
Research!America's 22nd annual Advocacy Awards will pay special tribute to The Honorable John Edward Porter, Research!America Chair Emeritus, for his decades-long commitment to advancing medical and health research. Porter served as a US Congressman from the 10th district in Illinois from 1980 to 2001 during which time he chaired the House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies.

Contact: Anna Briseno

Public Release: 26-Sep-2017
Scientists unlock mysteries of how Ebola uses people's immune defenses to cause infection
Scientists from the University of Texas Medical Branch at Galveston have gained new insight into how the Ebola virus uses the body's natural defenses to speed the rate of infection and unleash its lethal disease, according to a new report in mBio. The study was conducted in collaboration with the University of Washington and the National Institute of Allergy and Infectious Diseases.

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 26-Sep-2017
Nature Communications
Potential Zika vaccine protects against pregnancy transmission and testicular damage
For the first time, a collaborative team led by The University of Texas Medical Branch at Galveston has shown that a potential Zika vaccine quickly can protect fetuses against infection as well as protect males against testicular infection and injury. It also prevents a lowered sperm count after one vaccination. The findings are currently available in Nature Communications.

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 26-Sep-2017
OUP offers free journals access through EAI in response to hurricanes, earthquake
Oxford University Press (OUP) is partnering with the National Library of Medicine (NLM) as they launch their Emergency Access Initiative (EAI) to provide free access to biomedical research for healthcare professionals and aid workers responding to hurricanes Harvey, Irma, Maria, and the earthquake in Mexico.

Contact: Daniel Luzer
Oxford University Press USA

Public Release: 26-Sep-2017
Journal of Women's Health
Applying research advances to improve cardiovascular health in women
Cardiovascular disease remains the main cause of death among women, but evidence-based advances are enhancing clinical care in seven key areas, improving the lives of women living with and at risk for heart disease.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 26-Sep-2017
Scientific Reports
Discovering potential therapeutic protein inhibitors for Chagas disease
Scientists at Tokyo Institute of Technology (Tokyo Tech), Nagasaki University have identified four potential protein inhibitors and unlocked drug discovery strategies for the treatment of Chagas disease by using advanced three-dimensional computer simulation by supercomputer TSUBAME in combination with in vitro experiments and X-ray crystallography. Through this "smart drug discovery" in which IT drug discovery and biochemical experiments cooperate, they identified hit compounds for target protein with a hit rate of 20 times or more than conventional High Throughput Screening (HTS) methods.

Contact: Emiko Kawaguchi
Tokyo Institute of Technology

Public Release: 26-Sep-2017
Serum Institute's vaccine demonstrates significant efficacy against severe rotavirus
Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd.'s rotavirus vaccine BRV-PV (known as ROTASIIL®) were published in the journal Vaccine. The study showed the vaccine to be safe, well tolerated, and to provide significant efficacy against severe rotavirus gastroenteritis. In 2013, an estimated 47,100 rotavirus deaths occurred in India, 22 percent of all rotavirus deaths that occurred globally.

Contact: Kate Davidson

Public Release: 25-Sep-2017
ASTRO's 59th Annual Meeting
International trial confirms safety, effectiveness of HDR brachytherapy for cervical cancer
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy, or internal radiation therapy, for managing locally advanced cervical cancer. Tumor control was significantly better following four fractions of 7 Gray (Gy) each than following two, 9-Gy fractions of high-dose-rate (HDR) brachytherapy, but neither overall survival nor severe treatment-related side effects differed between the treatment groups.

Contact: Liz Gardner
American Society for Radiation Oncology

Public Release: 25-Sep-2017
Nature Immunology
Human antibodies from dengue patients can effectively treat Zika infection in mice
Scientists have discovered that antibodies taken from patients infected with dengue virus are effective in treating Zika infection in rodents.

Contact: Ryan O'Hare
Imperial College London

Public Release: 21-Sep-2017
Toilets for $10 or less are accelerating progress towards a major goal: Sanitation for all
The Water Innovation Engine, a pioneering partnership led by the Australian Government's Department of Foreign Affairs and Trade (DFAT) to stimulate bold new ideas and approaches in the water sector, today launched the global "Urban Sanitation Challenge" with the announcement of a multi-million dollar investment in five projects.
Grand Challenges Canada

416-583-5821 x5564
Grand Challenges Canada

Public Release: 20-Sep-2017
ASSAY and Drug Development Technologies
New quality control method to select effective MβCD for treating Neimann-Pick disease
Researchers have developed a quality control method to evaluate the pharmacological activity and potential effectiveness of different preparations of the therapeutic agent methyl-β-cyclodextrin (MβCD).

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 20-Sep-2017
$11.5 million program project aims to combat malaria drug resistance
Texas Biomed researchers have partnered with researchers at Notre Dame and the CIDR in Seattle to pursue studies in drug resistant malaria.
NIH/National institute of Allergy and Infectious Diseases

Contact: Lisa Cruz
Texas Biomedical Research Institute

Public Release: 20-Sep-2017
UNIST to track the spread of deadly avian influenza
South Korea's Ulsan National Institute of Science and Technology has embarked on a research project to develop a new type of tracking device, capable of monitoring the migration routes of wild birds.
Ministry of Science and ICT, Information Technology Research Center, Institute for Information and communications Technology Promotion

Contact: JooHyeon Heo
Ulsan National Institute of Science and Technology(UNIST)

Public Release: 20-Sep-2017
European Heart Journal: Acute Cardiovascular Care
Treatment of heart attack patients depends on history of cancer
Treatment of heart attack patients depends on their history of cancer, according to research published today in European Heart Journal: Acute Cardiovascular Care. The study in more than 35,000 heart attack patients found they were less likely to receive recommended drugs and interventions, and more likely to die in hospital if they had cancer than if they did not.

Contact: ESC Press Office
European Society of Cardiology

Public Release: 19-Sep-2017
5 African countries approach control of their HIV epidemics
Data released today from the US President's Emergency Plan for AIDS Relief (PEPFAR) show that the HIV epidemic is coming under control in Lesotho. These results add to prior PEPFAR-supported Population-based HIV Impact Assessments (PHIAs) announced in the last nine months for Malawi, Swaziland, Zambia, and Zimbabwe. Together, these data demonstrate impressive progress toward controlling the HIV epidemics in the five countries.

Contact: Stephanie Berger
Columbia University's Mailman School of Public Health

Public Release: 19-Sep-2017
The Lancet
India has avoided 1 million child deaths since 2005, new study concludes
India has avoided about 1 million deaths of children under age five since 2005, driven by significant reductions in mortality from pneumonia, diarrhea, tetanus and measles, according to new research published today.

Contact: Leslie Shepherd
St. Michael's Hospital

Public Release: 15-Sep-2017
Science Immunology
'Exciting' discovery on path to develop new type of vaccine to treat global viruses
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.
Wellcome Trust, Medical Research Council

Contact: Andrew White
University of Southampton

Public Release: 15-Sep-2017
$3 million collaboration to develop new approaches for HIV therapy
A collaboration between the University of Liverpool and the Johns Hopkins University School of Medicine (JHUSM) has been awarded a further $3m (£2.2m) to develop sophisticated new medicines for HIV.
National Institutes of Health

Contact: Simon Wood
University of Liverpool

Public Release: 15-Sep-2017
Nature Communications
Carbohydrates may be the key to a better malaria vaccine
An international research team has shown for the first time that carbohydrates on the surface of malaria parasites play a critical role in malaria's ability to infect mosquito and human hosts. The discovery also suggests steps that may improve the only malaria vaccine approved to protect people against Plasmodium falciparum malaria -- the most deadly form of the disease.
Australian National Health and Medical Research Council, Australian Research Council, Human Frontiers Science Program, Ramaciotti Foundation, University of Melbourne, veski, Victorian State Government Operational Infrastructure Support Program

Contact: Liz Williams
Walter and Eliza Hall Institute

Showing releases 101-125 out of 1416.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>